Efficacy and Safety of Biologics for Chronic Rhinosinusitis With Nasal Polyps.
- Published in:
- Journal of Pharmacy Technology, 2022, v. 38, n. 5, p. 289, doi. 10.1177/87551225221105749
- By:
- Publication type:
- Article
Works matching IS 87551225 AND DT 2022 AND VI 38 AND IP 5
Results: 7
1
2
Olanzapine/Samidorphan: A New Option for the Treatment of Adults With Schizophrenia or Bipolar I Disorder.
- Published in:
- Journal of Pharmacy Technology, 2022, v. 38, n. 5, p. 304, doi. 10.1177/87551225221114281
- By:
- Publication type:
- Article
3
Effect of Antidepressants on Glucagon-Like Peptide-1 Receptor Agonist-Related Weight Loss.
- Published in:
- Journal of Pharmacy Technology, 2022, v. 38, n. 5, p. 283, doi. 10.1177/87551225221110850
- By:
- Publication type:
- Article
4
Medication Use Among Patients Reporting Xerostomia of an Academic Dental Clinic.
- Published in:
- Journal of Pharmacy Technology, 2022, v. 38, n. 5, p. 264, doi. 10.1177/87551225221108599
- By:
- Publication type:
- Article
5
Early Experience With Interleukin-6 Receptor Antagonists in Patients With COVID-19 Admitted to a Community Hospital.
- Published in:
- Journal of Pharmacy Technology, 2022, v. 38, n. 5, p. 255, doi. 10.1177/87551225221104323
- By:
- Publication type:
- Article
6
Daridorexant: A New Dual Orexin Receptor Antagonist for Insomnia.
- Published in:
- Journal of Pharmacy Technology, 2022, v. 38, n. 5, p. 297, doi. 10.1177/87551225221112546
- By:
- Publication type:
- Article
7
The Role of Clinical Pharmacist in Pediatrics' Adherence to Antiepileptic Drugs.
- Published in:
- Journal of Pharmacy Technology, 2022, v. 38, n. 5, p. 272, doi. 10.1177/87551225221097619
- By:
- Publication type:
- Article